Search for: "Mylan Pharmaceuticals"
Results 541 - 560
of 739
Sort by Relevance
|
Sort by Date
11 Aug 2010, 1:03 pm
This court does not detect a situation such as the one occurred in Mylan. [read post]
4 Aug 2010, 12:21 am
Mylan Pharmaceuticals Inc. [read post]
1 Aug 2010, 9:59 pm
• Defendant: Mylan Pharmaceuticals Inc. [read post]
29 Jul 2010, 9:49 pm
By James DeGiulio -- Medicis Pharmaceuticals Settles Solodyn Litigation with Mylan Medicis Pharmaceuticals Corporation has reached settlement and license agreements with Mylan, Inc., thus resolving the patent litigation over Solodyn. [read post]
29 Jul 2010, 10:24 am
’s (“Caraco”) and Sun Pharmaceutical Laboratories, Ltd. [read post]
28 Jul 2010, 12:06 am
(Patent Docs) Namenda (Memantine) – US: Mylan announces settlement agreement with Forest Lab’s and Merz Pharmaceuticals (SmartBrief) Olux-E (Clobetasol) – US: Patent infringement complaint following a Paragraph IV certification: Stiefel Laboratories Inc. et al. v. [read post]
12 Jul 2010, 9:40 am
Mylan Pharmaceuticals Inc., C.A. 09-184-... [read post]
9 Jul 2010, 3:24 pm
As one of the leading manufacturers of generic drugs in the world, Mylan received final approval by the Food and Drug Administration (FDA) in 2009 to manufacture a generic substitute for the anti-seizure medication, Keppra, developed by UCB Pharmaceuticals Inc. and marketed to epilepsy patients. [read post]
8 Jul 2010, 1:25 pm
Several amicus briefs have been filed in the case in support of Caraco’s rehearing petition, including briefs from GPhA, Mylan, Teva, Apotex, and the Consumers Federation of America. [read post]
8 Jul 2010, 7:38 am
Mylan Pharm. [read post]
30 Jun 2010, 5:52 am
Mylan Pharmaceuticals Inc. et al. [read post]
29 Jun 2010, 6:01 pm
Mylan Pharmaceuticals Inc. et al. [read post]
24 Jun 2010, 1:47 pm
Co., a case involving coverage for underlying complaints alleging antitrust violations and fraud in the marketing of generic pharmaceuticals. [read post]
23 Jun 2010, 10:28 pm
Mylan Inc. et al. [read post]
20 Jun 2010, 8:51 pm
LLC; Sugen Inc.; C P Pharmaceuticals International CV • Defendants: Mylan Inc.; Mylan Pharmaceuticals Inc. [read post]
16 Jun 2010, 4:06 pm
Plaintiff Bernice Gainer brought a product liability claim against Mylan Pharmaceuticals arising from alleged injuries from the generic version of the drug, Dilantin, and its active ingredient Phenytoin. [read post]
3 Jun 2010, 5:35 am
– In re Ciprofloxacin Antitrust Litigation (PatLit) Circumvent PCV and Porcilis PCV vaccines – US: Wyeth files patent infringement suit against Intervet based on their manufacture of PCV vaccines (Patent Docs) Copegus (Ribavirin) – US: Ascio seeks declaratory judgment of unenforceability, invalidity and non-infringement of Three Rivers’ patent based on ANDA filing (Patent Docs) Entocort (Budesonide) – US: AstraZeneca settles Entocort patent suit with Teva, stipulates… [read post]
19 May 2010, 10:16 am
Mylan Pharmaceuticals, L.P., C.A. [read post]
5 May 2010, 4:46 am
Mylan Pharmaceuticals Inc. et al. [read post]
27 Apr 2010, 10:58 pm
Solstice International Partners et al (Docket Report) US: FTC annual report highlights the Commission’s patent settlement efforts (FDA Law Blog) Products Adcirca (Tadalafil) – US: Declaratory judgement of non-infringement and invalidity based on ANDA to manufacture generic Adcirca: Synthon v Eli Lilly et al (Patent Docs) Amrix (Cyclobenzaprine) – US: Mylan seeks declaratory judgment of noninfringement, unenforceability and invalidity of Amrix patent, based on… [read post]
